Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population

Abroad (travel likely)Recruiting

Conditions

Hidradenitis Suppurativa

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Novartis Investigative Site, Ancona, AN, Italy

  • Novartis Investigative Site, Bari, BA, Italy

  • Novartis Investigative Site, Brescia, BS, Italy

  • Novartis Investigative Site, Cona, FE, Italy

  • Novartis Investigative Site, Florence, FI, Italy

  • Novartis Investigative Site, Genova, GE, Italy

  • Novartis Investigative Site, Lecce, LE, Italy

  • Novartis Investigative Site, Messina, ME, Italy

  • Novartis Investigative Site, Milan, MI, Italy

  • Novartis Investigative Site, Rozzano, MI, Italy

  • Novartis Investigative Site, San Donato Milanese, MI, Italy

  • Novartis Investigative Site, Palermo, PA, Italy

  • Novartis Investigative Site, Perugia, PG, Italy

  • Novartis Investigative Site, Trento, TN, Italy

  • Novartis Investigative Site, Udine, UD, Italy

  • Novartis Investigative Site, Naples, Italy

Study leads
  • Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals